Home>Drug Target Models>Class C(Glutamate)

GRM2

GRM2 (mGlu2) is a group II metabotropic glutamate receptor enriched in the central nervous system. Activation of GRM2 inhibits adenylate cyclase and modulates neurotransmitter release and synaptic homeostasis. It also regulates the PI3K/AKT pathway, involving nicotine response and amine transport modulation. Our GRM2 stable cell lines are validated for cAMP assays to support your drug discovery programs.

Contact us

Name

Phone

Email*

Service & Products Interested*

Comments

submit
info@reqbio.com Email